The chemical class of potential TAF1D activators primarily consists of compounds that influence transcriptional regulation, particularly affecting RNA polymerase I activity and chromatin structure. These activators work by various mechanisms, such as intercalation into DNA, inhibition of transcription initiation, and modification of chromatin structure. For instance, Triptolide and Actinomycin D, both known for their potent effects on RNA polymerase, could indirectly modulate TAF1D's activity in the RNA polymerase I complex. Similarly, epigenetic modifiers like JQ1, RGFP966, Vorinostat, and Trichostatin A target the chromatin structure and histone modification processes, which are crucial for transcriptional regulation. By altering the chromatin landscape, these compounds can indirectly affect the transcription of ribosomal RNA genes, where TAF1D plays a significant role.
Moreover, the use of inhibitors like DRB, which targets RNA polymerase II, and C646, a p300/CBP histone acetyltransferase inhibitor, reflects the complex interplay between different transcriptional processes and the potential for cross-talk between RNA polymerase complexes. BIX-01294 and MLL1 inhibitors further expand this class by targeting histone methyltransferases, indicating the diverse mechanisms through which transcriptional regulation can be modulated, thereby indirectly influencing TAF1D's activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide is a diterpene triepoxide known to inhibit RNA polymerase I, potentially affecting TAF1D's function indirectly. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA and inhibits RNA polymerase, which could indirectly influence TAF1D's activity. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $240.00 | ||
CX-5461 selectively inhibits RNA polymerase I transcription initiation, potentially impacting TAF1D activity. | ||||||
BMH-21 | 896705-16-1 | sc-507460 | 10 mg | $165.00 | ||
BMH-21 binds to RNA polymerase I and disrupts its transcriptional activity, indirectly affecting TAF1D. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB inhibits RNA polymerase II, potentially altering transcriptional programs that indirectly affect TAF1D. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1, a BET bromodomain inhibitor, modulates transcription and could indirectly influence TAF1D's role in RNA polymerase I transcription. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
RGFP966, an HDAC3 inhibitor, can affect chromatin state and thereby indirectly influence transcription activities related to TAF1D. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat, an HDAC inhibitor, may indirectly affect TAF1D's function by altering chromatin structure and transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, another HDAC inhibitor, could indirectly influence TAF1D through changes in chromatin dynamics and transcription. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
C646 is a p300/CBP histone acetyltransferase inhibitor that could indirectly affect transcription processes involving TAF1D. |